HIV I Infection: Clinical Trials

8 trials for HIV I Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 2 completed, 1 terminated, 1 unknown. 8 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Recruiting 4, Completed 2, Terminated 1, Unknown 1
Phase 13Completed 1, Recruiting 1, Unknown 1

Follow HIV I Infection: new trials by email Literature Review of HIV I Infection trials Research Report on HIV I Infection

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without Antiretrovirals
Maraviroc, Dolutegravir, Dendritic Cell Vaccine - Hiv, HIV I Infection
Phase 2RecruitingFederal University of São Paulo702026-07-152026-08-19
Studying Topiramate for Re-Activating the HIV-1 Reservoir
Topiramate - HIV-1-infection, Hiv
Phase 1 / Phase 2UnknownErasmus Medical Center122024-09-012024-02-28
Evaluating the Safety and Immunogenicity of MTBVAC
MTBVAC, BCG - HIV I Infection, Tuberculosis
Phase 2RecruitingHIV Vaccine Trials Network2762024-01-302026-10-30
Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
Estradiol - HIV I Infection
Phase 2TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)932024-01-042026-04-08
Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
Adalimumab Injection - Tuberculous Meningitis, HIV I Infection
Phase 2RecruitingANRS, Emerging Infectious Diseases1302023-04-112025-12-15
Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy
Nivolumab 10 MG/ML [Opdivo], Saline - HIV I Infection
Phase 1 / Phase 2RecruitingUniversity of Melbourne422023-01-242025-12-22
Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir
Romidepsin, Vacc-4x, rhuGM-CSF - HIV I Infection
Phase 1 / Phase 2CompletedBionor Immuno AS262014-03-012017-03-01
Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV
Vacc-4x, Sterile water - HIV I Infection
Phase 2CompletedBionor Immuno AS1372008-08-012017-02-23

Narrower conditions

Acquired Immunodeficiency Syndrome (2)  ·  HIV Infections (1)  ·  Shock (1)  ·  Tuberculosis (1)  ·  Tuberculosis, Meningeal (1)

Broader conditions

Infections (4)  ·  Actinomycetales Infections (2)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Blood-Borne Infections (2)  ·  Communicable Diseases (2)  ·  Genital Diseases (2)  ·  Gram-Positive Bacterial Infections (2)  ·  Immune System Diseases (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Lentivirus Infections (2)  ·  Mycobacterium Infections (2)  ·  RNA Virus Infections (2)  ·  Retroviridae Infections (2)  ·  Sexually Transmitted Diseases (2)

Interventions

Vacc-4x (2)  ·  Adalimumab (1)  ·  Auranofin (1)  ·  Estradiol (1)  ·  MTBVAC vaccine (1)  ·  Maraviroc (1)  ·  Niacinamide (1)  ·  Nivolumab (1)  ·  Sodium Chloride (1)  ·  Topiramate (1)  ·  dolutegravir (1)  ·  lentiviral minigene vaccine of COVID-19 coronavirus (1)  ·  romidepsin (1)  ·  sargramostim (1)

Sponsors

Bionor Immuno AS (2)  ·  ANRS, Emerging Infectious Diseases (1)  ·  Erasmus Medical Center (1)  ·  Federal University of São Paulo (1)  ·  HIV Vaccine Trials Network (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  University of Melbourne (1)

Countries

Brazil (2)  ·  United States (2)  ·  Australia (1)  ·  Denmark (1)  ·  Germany (1)  ·  Italy (1)  ·  Mexico (1)  ·  Mozambique (1)  ·  Netherlands (1)  ·  Peru (1)  ·  Singapore (1)  ·  South Africa (1)  ·  Spain (1)  ·  Thailand (1)  ·  United Kingdom (1)

Top investigators

Jordan E. Lake, MD, MSc (1)  ·  Jorge A. Gallardo-Cartagena, MD (1)  ·  Kimberly K. Scarsi, PharmD, MS, FCCP (1)  ·  Limakatso Lebina (1)  ·  Mark Hatherill (1)  ·  Richard Pollard, MD (1)  ·  Sharon Lewin (1)

Results publications

PMID 24525316, PMID 26379282, PMID 27658863